EC
SGMO

EcoR1 Capital’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

EcoR1 Capital’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,308,079
Closed -$14.7M – 65
2020
Q1 		$14.7M Buy
+2,308,079
New +$17.1M 1.54% 20
2019
Q1 		– Sell
-1,185,831
Closed -$13.6M – 52
2018
Q4 		$13.6M Buy
1,185,831
+842,600
+245% +$10.5M 1.36% 22
2018
Q3 		$5.82M Sell
343,231
-1,166,440
-77% -$17.7M 0.52% 33
2018
Q2 		$21.4M Buy
+1,509,671
New +$25.1M 2.04% 16
2017
Q4 		– Sell
-222,388
Closed -$3.34M – 41
2017
Q3 		$3.34M Sell
222,388
-2,345,731
-91% -$25.9M 0.44% 28
2017
Q2 		$22.6M Buy
+2,568,119
New +$16.5M 4.01% 8

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EcoR1 Capital's SGMO Position: Q2 2020 in Review

EcoR1 Capital sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2020, closing a stake of 2,308,079 shares — an estimated $14.7M sold.

EcoR1 Capital first reported a position in SGMO in Q2 2017 and held it in 6 quarters. The position peaked at $22.6M in Q2 2017. 205 funds tracked by Wall St. Rank hold SGMO as of Q2 2020.

  • EcoR1 Capital reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2020 after selling out during the quarter.
  • EcoR1 Capital sold 2,308,079 SANGAMO THERAPEUTICS INC shares in Q2 2020, an estimated $14.7M.
  • EcoR1 Capital first reported a position in SANGAMO THERAPEUTICS INC in Q2 2017 and held it in 6 quarters.
  • EcoR1 Capital's SANGAMO THERAPEUTICS INC position peaked at $22.6M in Q2 2017.
  • 205 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2020.

Based on EcoR1 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.